Archive


Category: BPEA

  • Boston Scientific Signs an Agreement with BPEA to Acquire Lumenis’ Surgical Business

    Shots: Boston Scientific to acquire the global surgical business of Lumenis for $1.07B as an up front in cash. The transaction is expected to be completed in H2’21 BPEA will retain ownership of the Lumenis global aesthetics and ophthalmology businesses. The acquisition will expand Boston Scientific’s global kidney stone management portfolio and will expand its […]